What are the latest evidence on ultra-thin stenting for the treatment of high-risk patients?

In this discussion, Ashok Seth, Abishek Kumar and Simone Biscaglia explore how to optimise PCI outcomes in increasingly complex and high-risk patients, balancing ischaemic benefit and bleeding risk. They highlight the growing role of ultra-thin strut stents, supported by recent trials and registries that show improved outcomes, reduced stent thrombosis, and the possibility of shorter DAPT, even in elderly and high-bleeding-risk populations. The key message: with appropriate patient selection, imaging guidance and modern stent platforms, it is possible to achieve both effective revascularisation and safer antithrombotic strategies, even in the most challenging clinical scenarios.

This interview was filmed at EuroPCR 2026: see more videos here.